Published 15 hours ago • loading... • Updated 15 hours ago

UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says

Summary by CNBC

Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U.S. policymakers.

Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U.S. policymakers.

15 hours ago·United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated14 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States 15 hours ago on Tuesday, September 16, 2025.

Sources are mostly out of (0)